Patrick J. McEnany sold Catalyst Pharmaceuticals ($CPRX) shares on the open market twice in the last year, totaling $5.2 million. His most recent sale occurred on June 9, 2025. These sales rank 1,875th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.37 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | F | Common Stock, par value $0.001 per share | 6786 | $0.00 | 4,171,559.0000 | 127,201,954 | 0.16% | 0.01% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 26334 | $0.00 | 1,851,948.0000 | 127,201,954 | 1.40% | 0.02% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 26334 | $0.00 | 4,178,345.0000 | 127,201,954 | 0.63% | 0.02% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 3534 | $0.00 | 4,152,011.0000 | 127,201,954 | 0.09% | 0.00% |
| Dec. 8, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 3534 | $0.00 | 1,878,282.0000 | 127,201,954 | 0.19% | 0.00% |
| Dec. 1, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | G | Common stock, par value $0.001 per share | 45000 | $0.00 | 4,193,477.0000 | 127,201,954 | 1.06% | 0.04% |
| Dec. 1, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | G | Common stock, par value $0.001 per share | 45000 | $0.00 | 4,328,477.0000 | 127,201,954 | 1.03% | 0.04% |
| Dec. 1, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | G | Common stock, par value $0.001 per share | 45000 | $0.00 | 4,148,477.0000 | 127,201,954 | 1.07% | 0.04% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 1775 | $0.00 | 1,881,816.0000 | 127,201,954 | 0.09% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 1775 | $0.00 | 4,283,477.0000 | 127,201,954 | 0.04% | 0.00% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | A | Restricted Stock Units | 10540 | $0.00 | 1,883,591.0000 | 127,201,954 | 0.56% | 0.01% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | A | Options to purchase common stock | 34921 | $0.00 | 1,873,051.0000 | 127,201,954 | 1.90% | 0.03% |
| June 6, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common Stock, par value $0.001 per share | 28252 | $25.95 | 4,453,450.0000 | 124,943,603 | 0.63% | 0.02% |
| June 9, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common Stock, par value $0.001 per share | 171748 | $26.11 | 4,281,702.0000 | 124,943,603 | 3.86% | 0.14% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 3533 | $0.00 | 1,838,130.0000 | 125,407,279 | 0.19% | 0.00% |
| Dec. 9, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 3533 | $0.00 | 4,481,702.0000 | 125,407,279 | 0.08% | 0.00% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | A | Restricted Stock Units | 5327 | $0.00 | 1,841,663.0000 | 125,407,279 | 0.29% | 0.00% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | A | Options to purchase common stock | 43591 | $0.00 | 1,836,336.0000 | 125,407,279 | 2.43% | 0.03% |
| Nov. 19, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 98345 | $21.19 | 4,478,169.0000 | 125,407,279 | 2.15% | 0.08% |
| Nov. 19, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 98345 | $3.54 | 4,576,514.0000 | 125,407,279 | 2.20% | 0.08% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 72500 | $3.54 | 4,550,669.0000 | 125,407,279 | 1.62% | 0.06% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 72500 | $21.29 | 4,478,169.0000 | 125,407,279 | 1.59% | 0.06% |
| Nov. 19, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 98345 | $0.00 | 1,865,245.0000 | 125,407,279 | 5.01% | 0.08% |
| Nov. 20, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 72500 | $0.00 | 1,792,745.0000 | 125,407,279 | 3.89% | 0.06% |
| Nov. 14, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 44655 | $21.75 | 4,478,169.0000 | 125,407,279 | 0.99% | 0.04% |
| Nov. 13, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 92500 | $0.00 | 2,008,245.0000 | 125,407,279 | 4.40% | 0.07% |
| Nov. 14, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 44655 | $0.00 | 1,963,590.0000 | 125,407,279 | 2.22% | 0.04% |
| Nov. 13, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 92500 | $3.54 | 4,570,669.0000 | 125,407,279 | 2.07% | 0.07% |
| Nov. 13, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 92500 | $22.98 | 4,478,169.0000 | 125,407,279 | 2.02% | 0.07% |
| Nov. 14, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 44655 | $3.54 | 4,522,824.0000 | 125,407,279 | 1.00% | 0.04% |
| Nov. 11, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 230000 | $0.00 | 2,362,745.0000 | 125,407,279 | 8.87% | 0.18% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 70000 | $0.00 | 2,292,745.0000 | 125,407,279 | 2.96% | 0.06% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 192000 | $0.00 | 2,100,745.0000 | 125,407,279 | 8.37% | 0.15% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 192000 | $23.20 | 4,478,169.0000 | 125,407,279 | 4.11% | 0.15% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 192000 | $3.54 | 4,670,169.0000 | 125,407,279 | 4.29% | 0.15% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 70000 | $23.42 | 4,478,169.0000 | 125,407,279 | 1.54% | 0.06% |
| Nov. 12, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 70000 | $4.01 | 4,548,169.0000 | 125,407,279 | 1.56% | 0.06% |
| Nov. 11, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | S | Common stock, par value $0.001 per share | 230000 | $23.55 | 4,478,169.0000 | 125,407,279 | 4.89% | 0.18% |
| Nov. 11, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 230000 | $4.01 | 4,708,169.0000 | 125,407,279 | 5.14% | 0.18% |
| Aug. 22, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | G | Common Stock, par value $0.001 per share | 5100 | $0.00 | 4,478,169.0000 | 113,753,154 | 0.11% | 0.00% |
| Aug. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | G | Common Stock, par value $0.001 per share | 45000 | $0.00 | 4,483,269.0000 | 113,753,154 | 0.99% | 0.04% |
| Jan. 30, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 116667 | $0.00 | 2,592,745.0000 | 113,753,154 | 4.31% | 0.10% |
| Jan. 30, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 26333 | $0.00 | 4,411,589.0000 | 113,753,154 | 0.60% | 0.02% |
| Jan. 30, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common Stock, par value $0.001 per share | 116667 | $0.00 | 4,528,256.0000 | 113,753,154 | 2.64% | 0.10% |
| Jan. 30, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Restricted Stock Units | 26333 | $0.00 | 2,709,412.0000 | 113,753,154 | 0.96% | 0.02% |
| Jan. 2, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Options to purchase common stock | 250000 | $0.00 | 2,735,745.0000 | 113,753,154 | 8.37% | 0.22% |
| Jan. 2, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Other | M | Common stock, par value $0.001 per share | 250000 | $1.13 | 4,385,256.0000 | 113,753,154 | 6.05% | 0.22% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Common Stock, par value $0.001 per share | 26333 | $0.00 | 4,145,618.0000 | 111,375,631 | 0.64% | 0.02% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | F | Common Stock, par value $0.001 per share | 10362 | $0.00 | 4,135,256.0000 | 111,375,631 | 0.25% | 0.01% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Restricted Stock Units | 26333 | $0.00 | 2,985,745.0000 | 111,375,631 | 0.87% | 0.02% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Chairman and CEO | A | Options to purchase common stock | 73810 | $0.00 | 3,001,477.0000 | 111,375,631 | 2.52% | 0.07% |
| Dec. 8, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | Chairman and CEO | A | Restricted Stock Units | 10601 | $0.00 | 3,012,078.0000 | 111,375,631 | 0.35% | 0.01% |
| May 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Options to purchase common stock | 26151 | $0.00 | 3,101,516.0000 | 111,375,631 | 0.84% | 0.02% |
| May 16, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Common stock, par value $0.001 per share | 173849 | $0.79 | 4,119,285.0000 | 111,375,631 | 4.41% | 0.16% |
| May 16, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Options to purchase common stock | 173849 | $0.00 | 2,927,667.0000 | 111,375,631 | 5.61% | 0.16% |
| May 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | S | Common stock, par value $0.001 per share | 26151 | $13.23 | 3,945,436.0000 | 111,375,631 | 0.66% | 0.02% |
| May 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Common stock, par value $0.001 per share | 26151 | $0.79 | 3,971,587.0000 | 111,375,631 | 0.66% | 0.02% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Restricted Stock Units | 58333 | $0.00 | 3,127,667.0000 | 111,375,631 | 1.83% | 0.05% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | F | Common Stock, par value $0.001 per share | 14204 | $0.00 | 3,945,436.0000 | 111,375,631 | 0.36% | 0.01% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | MCENANY PATRICK J | President and CEO | M | Common Stock, par value $0.001 per share | 58333 | $0.00 | 3,959,640.0000 | 111,375,631 | 1.50% | 0.05% |